EN DE
STOCK COMPARISON

Abbott Laboratories vs Senzime AB: Fair Value & Quality

Both stocks run through our valuation models. Here is how Abbott Laboratories (ABT) and Senzime AB (SEZI) compare, as of Sep 28, 2026.

As of Sep 28, 2026, Fair Value Calculator sees Abbott Laboratories as the less overvalued of the two: Abbott Laboratories trades at $101 versus a fair value of $74.79 (−26.2%), while Senzime AB trades at SEK 2.42 versus SEK 0.34 (−86.0%).
Abbott Laboratories
ABT · USD · Health Care
−26.2%
upside to fair value
overvalued
Price$101
Fair Value$74.79
Quality66/100
Senzime AB
SEZI.ST · SEK · Health Care
−86.0%
upside to fair value
overvalued
PriceSEK 2.42
Fair ValueSEK 0.34
Quality38/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green is the better side of a row, red the weaker one (for valuation multiples: lower = cheaper). Grey rows are for reference only and are not scored.

betterweakerfor reference, not scored

Abbott LaboratoriesSenzime AB
Valuation
33.5×P/E (TTM)n/a
16.7×Forward P/E (FY2027)n/a
33.6×Median P/E at FY-end (9 FY, ex one-offs where documented)n/a
3.79×P/S (TTM)0.64×
3.39×P/B0.22×
15.2×EV/EBITDAn/a
1.90×PEGn/a
−26.2%Fair value upside−86.0%
2.4%Dividend yieldn/a
$2.48Dividend per sharen/a
Profitability
14.7%Operating margin-111.4%
1.19×EBIT margin trend (5Y)n/a
10.6%Return on equity-42.5%
5.3%Return on assets-20.4%
Growth
13.0%Revenue growth (YoY)-1.1%
0.5%Avg. growth/yr (3Y)95.0%
5.1%Avg. growth/yr (5Y)62.0%
+10.6%Value creation/yrn/a
Balance & size
23.6×Interest coverage (EBIT/interest)n/a
0.19×Debt / equityn/a
$177BMarket cap$66M
healthyGrowth qualitymixed
Abbott Laboratories, median P/E at fiscal year-end, 9 fiscal years (2016 to 2025), reported earnings, FY2016, FY2020 ex one-offs: 33.6.
Forward P/E: price divided by the analyst consensus for the first fiscal year that has not started yet. The current year carries special items from quarters already reported.

Even match: 4 to 4 metric wins.

n/a = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Abbott Laboratoriesof which business quality 66 · market factors 48 Senzime ABof which business quality 38 · market factors 17
ProfitabilityMargins and returns on capital today
50
5
Quality GrowthAre margins and returns improving?
47
61
CashflowEarnings quality: real cash, not paper profit
71
7
Fin. StrengthBalance sheet, leverage, solvency risk
80
87
InvestmentDisciplined investing over empire-building
65
83
Low VolatilityCalm price path (market factor)
84
57
MomentumPrice trend over the last 3–12 months (market factor)
39
0
52W MomentumDistance to the 52-week high (market factor)
24
0
Net IssuanceShare count: buybacks or dilution?
83
0

What the models say

How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.

above the price, more than 15% above close to the price, 85% to 115% of the price below the price, more than 15% below

Model familyAbbott LaboratoriesPrice $101Senzime ABPrice SEK 2.42
DCF Models−26.2%below the price$74.80n/a
Earnings-Based−71.0%below the price$29.42n/a
Dividend Discount−60.8%below the price$39.73n/a
Multiples−30.2%below the price$70.72n/a
Asset-Based−80.2%below the price$20.05−46.3%below the priceSEK 1.30
Growth DCF−32.3%below the price$68.58n/a
Economic Profit−63.0%below the price$37.49n/a
Growth Earnings−30.6%below the price$70.25n/a
Minimum−80.2%below the price$20.05−46.3%below the priceSEK 1.30
Maximum−26.2%below the price$74.80−46.3%below the priceSEK 1.30
Median−46.5%below the price$54.15−46.3%below the priceSEK 1.30
Geometric mean−54.0%below the price$46.64−46.3%below the priceSEK 1.30

Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.

Abbott Laboratories: 26 of 26 models see the stock below the current price.

Senzime AB: 1 of 1 models see the stock below the current price.

Scenario ranges

From our cautious bear scenario to the optimistic bull scenario. The white tick is the current price (value above it), the green tick the fair value (value below it): if the price sits left of the fair value, there is room to rise.

Abbott Laboratories
Price $101
Fair Value $74.79
Bear $52.28Bull $94.43
Senzime AB
Price SEK 2.42
Fair Value SEK 0.34
Bear SEK 0.22Bull SEK 0.43

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Abbott Laboratories · Health Care

Quality score66 · Top 25%
Fair value upside−26.2% · below median

Senzime AB · Health Care

Quality score38 · bottom 25%
Fair value upside−86.0% · bottom 25%

Bottom line

As of Sep 28, 2026, Fair Value Calculator sees Abbott Laboratories as the less overvalued of the two: Abbott Laboratories trades at $101 versus a fair value of $74.79 (−26.2%), while Senzime AB trades at SEK 2.42 versus SEK 0.34 (−86.0%).

Abbott Laboratories has the higher quality score (66/100).

Open Abbott Laboratories live analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.